Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glabellar Frown Lines”

84 trials

Showing 20 of 84 results

Testing effectiveness (Phase 2)Study completedNCT03736928
What this trial is testing

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 401
Testing effectiveness (Phase 2)Study completedNCT02236312
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 359
Testing effectiveness (Phase 2)Study completedNCT03786770
What this trial is testing

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)

Who this might be right for
Frown Lines
Revance Therapeutics, Inc. 61
Not applicableActive Not RecruitingNCT05481931
What this trial is testing

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 756
Testing effectiveness (Phase 2)Study completedNCT02303002
What this trial is testing

Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Revance Therapeutics, Inc. 268
Very early researchUnknownNCT05083286
What this trial is testing

Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)Study completedNCT04594213
What this trial is testing

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines

Who this might be right for
Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)
Merz North America, Inc. 362
Testing effectiveness (Phase 2)Study completedNCT03806933
What this trial is testing

Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

Who this might be right for
Moderate to Severe Glabellar Frown Lines
Merz Aesthetics GmbH 241
Large-scale testing (Phase 3)Study completedNCT05059587
What this trial is testing

Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 318
Very early researchStudy completedNCT05129319
What this trial is testing

Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 30
Large-scale testing (Phase 3)Study completedNCT03985982
What this trial is testing

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)

Who this might be right for
Glabellar Frown Lines
Croma-Pharma GmbH 410
Post-approval studies (Phase 4)Study completedNCT01814670
What this trial is testing

Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines

Who this might be right for
Glabellar Rhytides
Allergan 185
Post-approval studies (Phase 4)Study completedNCT03687736
What this trial is testing

Subject Satisfaction With AbobutulinumtoxinA Treatment

Who this might be right for
Glabellar Frown Lines
Galderma R&D 120
Testing effectiveness (Phase 2)Study completedNCT02184988
What this trial is testing

Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 352
Not applicableStudy completedNCT01801826
What this trial is testing

A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device

Who this might be right for
Frown LinesGlabellar Frown Lines
Pacira Pharmaceuticals, Inc 61
Testing effectiveness (Phase 2)Study completedNCT04259086
What this trial is testing

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines

Who this might be right for
Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)
Revance Therapeutics, Inc. 48
Large-scale testing (Phase 3)Study completedNCT03014635
What this trial is testing

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Revance Therapeutics, Inc. 306
Large-scale testing (Phase 3)Study completedNCT03960957
What this trial is testing

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 301
Post-approval studies (Phase 4)Study completedNCT01391312
What this trial is testing

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Who this might be right for
Glabellar Frown Lines
Allergan 40
Large-scale testing (Phase 3)Study completedNCT05148000
What this trial is testing

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Who this might be right for
Glabellar Frown LinesCanthal Lines
Galderma R&D 25
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation